Corbion N.V. (AMS:CRBN)
Netherlands · Delayed Price · Currency is EUR | Market Cap | 1.27B +32.2% |
| Revenue (ttm) | 1.25B -3.4% |
| Net Income | 62.20M -6.0% |
| EPS | 1.06 -5.4% |
| Shares Out | 57.65M |
| PE Ratio | 20.83 |
| Forward PE | 15.41 |
| Dividend | 0.64 (2.90%) |
| Ex-Dividend Date | May 15, 2026 |
| Volume | 128,284 |
| Open | 21.66 |
| Previous Close | 21.60 |
| Day's Range | 21.64 - 22.10 |
| 52-Week Range | 16.37 - 23.14 |
| Beta | 0.87 |
| Analysts | Buy |
| Price Target | 23.41 (+6.02%) |
| Earnings Date | Oct 28, 2026 |
About Corbion
Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the rest of Europe, the Middle East, and Africa. It operates in two segments, Functional Ingredients & Solutions, and Health & Nutrition. The company offers antioxidants, fermentation and preservation ingredients, flavors, fortification, functional blends, and lactic acid lactates and derivatives; AlgaPrime DHA, an omega-3 sourcing ... [Read more]
Financial Performance
In 2025, Corbion's revenue was 1.27 billion, a decrease of -1.61% compared to the previous year's 1.29 billion. Earnings were 74.80 million, a decrease of -61.08%.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for CRBN stock is "Buy." The 12-month stock price target is €23.41, which is an increase of 6.02% from the latest price.
News
Corbion Earnings Call Transcript: H1 2026
Organic sales grew 2.1% in H1 2026, with Q2 accelerating to 8.5% organic growth and strong volume/mix. Adjusted EBITDA margin outlook was refined to above 16% due to higher raw material costs, while free cash flow and sales growth guidance are maintained for the year.
Corbion Earnings release: H1 2026
Corbion released its H1 2026 earnings on July 31, 2026, summarizing the period's financial results.
Corbion Slides: H1 2026
Corbion has posted slides in relation to its H1 2026 quarterly earnings report, which was published on July 31, 2026.
Corbion General Shareholders Meeting approves Supervisory Board appointments and dividend
The annual Corbion General Shareholders Meeting held on 13 May 2026 approved the appointments of Per Falholt and Bob Elfring as members of the Supervisory Board.
Corbion Earnings Call Transcript: Q1 2026
Q1 2026 results showed lower sales and margins versus a strong prior year, but momentum is building with robust demand in core segments and cost reductions set to drive improvement from Q2. Full-year guidance is reaffirmed, with strong cash generation and margin recovery expected.
Corbion Earnings release: Q1 2026
Corbion released its Q1 2026 earnings on April 22, 2026, summarizing the period's financial results.
Corbion Slides: Q1 2026
Corbion has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 22, 2026.
Correction: Corbion announces quarterly sales of € 293.7m and Adjusted EBITDA of € 37.8m; maintains full-year outlook
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for Q1 2026 ending 31 March.
Corbion announces quarterly sales of € 293.7m and Adjusted EBITDA of € 37.8m; maintains full-year outlook
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for Q1 2026 ending 31 March.
Corbion published agenda for AGM
Corbion has published its agenda for the upcoming Annual General Meeting of Shareholders (AGM) to be held on 13 May 2026 . The full AGM agenda together with explanatory notes is available on Corbion's...
Corbion Earnings Call Transcript: H2 2025
Delivered strong organic growth, improved profitability, and robust free cash flow in 2025, with EPS up 63% and a proposed EUR 1 per share dividend. 2026 guidance targets 3%-6% organic sales growth, 17% EBITDA margin, and continued portfolio focus.
Corbion Earnings release: H2 2025
Corbion released its H2 2025 earnings on February 26, 2026, summarizing the period's financial results.
Corbion Slides: H2 2025
Corbion has posted slides in relation to its H2 2025 quarterly earnings report, which was published on February 26, 2026.
Corbion Annual report: H2 2025
Corbion has published its H2 2025 annual report on February 26, 2026.
Corbion announces strong full-year 2025 results with +26.7% organic Adjusted EBITDA growth, +63.3% EPS growth, and €90.8 million in FCF; announces special dividend
Corbion, the Amsterdam-listed sustainable food-ingredients company that champions preservation through application of science, today publishes its results for the year ending 31 December 2025.
Corbion Transcript: CMD 2025
Advance 2025 targets were met, including margin expansion and portfolio optimization. Bright 2030 sharpens focus on natural preservation, nutrition, and biomedical polymers, targeting 3%-6% annual sales growth, 18% EBITDA margin by 2028, and EUR 270 million cumulative free cash flow.
Corbion Press release: FY 2025
Corbion issued a press release on November 20, 2025, disclosing material business information to investors.
Corbion Slides: FY 2025
Corbion has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 20, 2025.
Corbion unveils BRIGHT 2030 strategy to lead in sustainable specialty food-ingredients; outlining its strategic path and medium-term financial targets
Corbion, the Amsterdam-listed sustainable food-ingredients company that champions preservation through application of science, will hold its Capital Markets Day for analysts and investors via live web...
Corbion reports the end of its share buyback program to cover commitments under its long-term employee incentive plan
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through application of science, today announces that it has completed the share buyback program which it start...
Corbion reports the progress of its share buyback program 3 November – 7 November 2025
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 3 November up to and including 7 November 2025 a total of 124.786 ...
Corbion signs a new debt issuance for USD 100 million in the US Private Placement market
Corbion announces the signing of a Note Purchase Agreement for a total debt issuance of USD 100 million in the US Private Placement (USPP) market, with a fixed interest rate of 5.11% and a maturity of...
Corbion reports the progress of its share buyback program 27 October – 31 October 2025
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 27 October up to and including 31 October 2025 a total of 102.003 ...
Corbion announces strong YTD EBITDA growth, and EBITDA margin improvement of +240 bps; full-year outlook maintained
Corbion Q3 2025 Interim Management Statement Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through application of science, today publishes its results for t...
Corbion reports the progress of its share buyback program 20 October – 24 October 2025
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 20 October up to and including 24 October 2025 a total of 22.669 s...